GLI1 and medulloblastoma: In addition, SMO inhibitor-resistant mouse medulloblastoma are still sensitive to PI3K inhibition (66) and combination therapy with the GLI inhibitor GANT61 and PI3K/MTOR inhibitor PI103 synergistically inhibited tumors in a HH-driven rhabdomyosarcoma mouse model (67).